Wall Street Analysts Think Nektar (NKTR) Could Surge 89.8%: Read This Before Placing a Bet

Shares of Nektar Therapeutics (NKTR) have gained 79.9% over the past four weeks to close the last trading session at $68.42, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $129.86 indicates a potential upside of 89.8%.The mean estimate comprises seven short-term price targets with a standard deviation of $25.1. While the lowest estimate of $102.00 indicates a 49.1% increase fro ...